Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AGILON HEALTH, INC.

(AGL)
  Report
Real-time Estimate Cboe BZX  -  09:56 2022-09-26 am EDT
22.61 USD   +0.78%
09/16AGILON HEALTH : September 2022 Investor Presentation
PU
09/14TRANSCRIPT : Agilon health, inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-14-2022 03:30 PM
CI
09/14Agilon health Initiated by RBC at Outperform With $33 Price Target; RBC Calls agilon its Favorite Among 'Tech-Enabled Providers'
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

agilon health Releases Inaugural ESG Report Launching Total Care, Healthier Communities Impact Strategy

08/09/2022 | 09:03am EDT

The company’s impact strategy is driven by the vision of transforming health care in 100+ communities through a sustainable value-based primary care model

agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today released its inaugural Total Care, Healthier Communities Impact Report highlighting the company’s Environmental, Social, and Governance (ESG) performance for 2021. The impact report reflects agilon health’s vision and commitment with its physician partners to transforming health care in 100+ communities through value-based primary care.

"Every day we are pursuing our mission to be the trusted, long-term partner of community-based physicians, enabling them to reimagine the patient experience for older adults and lead the transformation of care delivery in their communities,” said Steve Sell, Chief Executive Officer. “We are pleased to share our ESG strategy and inaugural report which articulates our commitment to building a new primary care model with our physician partners in a sustainable and responsible manner.”

Aligned to agilon’s impact pillars and based on a strong governance foundation, the comprehensive report provides an enterprise-wide analysis of the company’s ESG actions, programs, and investments. It also highlights the important role of key stakeholders including primary care physicians, patients, communities, and employees in delivering high-quality primary care within a full-risk, capitation model.

Key highlights from the Impact Report by strategic pillar include:

  • Empowering Physicians to focus on the total health of their senior patients: Through a sustainable model for primary care, 85% of providers at physician partners believe the quality-of-care programs created through the partnership with agilon have enabled better health. Patients being cared for by an agilon physician partner report a world-class NPS score of 80-plus.
  • Unlocking Value-Based Care to create a system based on the value of care, not the volume of fees: By participating in full-risk relationships that improve care and expand access to value-based primary care, 94% of patients agree that they receive comprehensive, high-quality care from their agilon physician partners. Providers at agilon physician partners have achieved 44% more touch points for their high-risk senior patients.
  • Transforming Communities to bring quality health care to those who need it most: Aligned with agilon’s vision of transforming health care in more than 100 communities nationwide, over the last four years, the company has reinvested more than $250 million in its physician partners and their communities to improve quality of care for seniors.
  • Built by People Who Care to create an environment where passionate people thrive: agilon fosters an inclusive, engaged culture that prioritizes health and well-being, and this is reflected in high scores among employees (84th percentile) for being proud of the work they do.
  • Strong Governance Foundation because doing business the right way is the only way: agilon’s commitment to governance is relevant to many of the company’s priorities: compliance with federal and state laws, safeguarding patient data, how agilon treats its employees and the planet, and the values that define the company.

To read the inaugural ESG report, including the full list of 2021 Impact Highlights, and to learn more about agilon, visit https://www.agilonhealth.com/esg-social-impact-strategy/.

About agilon health

agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups transition to a value-based Total Care Model for senior patients. agilon provides the technology, people, capital, process, and access to peer network that allow physician groups to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon will be the trusted partner in 17 diverse communities and is here to help more of our nation’s best physician groups and health systems have a sustained, thriving future. For more information go to www.agilonhealth.com connect with us on Twitter, Instagram, LinkedIn and YouTube.

Forward-Looking Statements

Statements in this release that are not historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” "target," “forecast,” “plan,” “potential,” “estimate,” “could,” “would,” “should,” and other comparable and derivative terms or the negatives thereof. Examples of forward-looking statements include, among other things: (i) statements regarding timing, outcomes and other details relating to current, pending or contemplated new markets, new partnership structures, financing activities, dispositions, or other transactions discussed in this release; and (ii) statements regarding growth opportunities, ability to deliver sustainable long-term value, business environment, long term opportunities and strategic growth plan including without limitation with respect to expected revenue and net income, total and average membership, Adjusted EBITDA, and other financial projections and assumptions, as well as comparable statements included in other sections of this release. Forward-looking statements reflect our current expectations and views about future events and are subject to risks and uncertainties that could significantly affect our future financial condition and results of operations. While forward-looking statements reflect our good faith belief and assumptions we believe to be reasonable based upon current information, we can give no assurance that our expectations or forecasts will be attained. Further, we cannot guarantee the accuracy of any such forward-looking statement contained in this release, and such forward-looking statements are subject to known and unknown risks and uncertainties that are difficult to predict. These risks and uncertainties that could cause actual results and outcomes to differ from those reflected in forward-looking statements include, but are not limited to: our history of net losses, and our ability to achieve or maintain profitability in an environment of increasing expenses; our ability to identify and develop successful new geographies, physician partners and payors, or to execute upon our growth initiatives; our ability to execute our operation strategies or to achieve results consistent with our historical performance; our expectation that our expenses will increase in the future and the risk that medical expenses incurred on behalf of members may exceed the amount of medical revenues we receive; our ability to secure contracts with Medicare Advantage payors or to secure Medicare Advantage payments at favorable financial terms; our ability to recover startup costs incurred during the initial stages of development of our physician partner relationships and program initiatives; significant reductions in our membership; challenges for our physician partners in the transition to a Total Care Model; inaccuracies in the estimates and assumptions we use to project the size, revenue or medical expense amounts of our target markets; the spread of, and response to, the novel coronavirus, or COVID-19, and the inability to predict the ultimate impact on us; security breaches, loss of data or other disruptions to our data platforms; the impact of devoting significant attention and resources to the provision of certain transition services in connection with the disposition of our California operations; our subsidiaries’ lack of performance or ability to fund their operations, which could require us to fund such losses; our dependence on a limited number of key payors; the limited terms of our contracts with payors and that they may not be renewed upon their expiration; our reliance on our payors for membership attribution and assignment, data and reporting accuracy and claims payment; our dependence on physician partners and other providers to effectively manage the quality and cost of care and perform obligations under payor contracts; our dependence on physician partners to accurately, timely and sufficiently document their services and potential False Claims Act or other liability if any diagnosis information or encounter data are inaccurate or incorrect; reductions in reimbursement rates or methodology applied to derive reimbursement from, or discontinuation of, federal government healthcare programs, from which we derive substantially all of our total revenue; statutory or regulatory changes, administrative rulings, interpretations of policy and determinations by intermediaries and governmental funding restrictions, and their impact on government funding, program coverage and reimbursements; regulatory proposals directed at containing or lowering the cost of healthcare and our participation in such proposed models; the impact on our revenue of CMS modifying the methodology used to determine the revenue associated with MA members; the potential that we may incur future indebtedness; and risks related to other factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021. Except as required by law, we do not undertake, and hereby disclaim, any obligation to update any forward-looking statements, which speak only as of the date on which they are made.


© Business Wire 2022
All news about AGILON HEALTH, INC.
09/16AGILON HEALTH : September 2022 Investor Presentation
PU
09/14TRANSCRIPT : Agilon health, inc. Presents at Morgan Stanley 20th Annual Global Healthcare ..
CI
09/14Agilon health Initiated by RBC at Outperform With $33 Price Target; RBC Calls agilon it..
MT
09/12INSIDER SELL : Agilon Health
MT
09/12Goldman Sachs Reinstates agilon health at Buy with $38 Price Target
MT
09/08TRANSCRIPT : Agilon health, inc. Presents at 2022 Wells Fargo Healthcare Conference, Sep-0..
CI
09/07Truist Securities Assumes agilon health at Buy, Sets $29 Price Target
MT
09/05MARKETSCREENER’S WORLD PRESS REVIEW : September 5, 2022
MS
08/29agilon health to Participate in Upcoming Investor Conferences
BU
08/25INSIDER SELL : Agilon Health
MT
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 2 633 M - -
Net income 2022 -68,8 M - -
Net cash 2022 867 M - -
P/E ratio 2022 -133x
Yield 2022 -
Capitalization 9 217 M 9 217 M -
EV / Sales 2022 3,17x
EV / Sales 2023 2,17x
Nbr of Employees 647
Free-Float 98,9%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 22,43 $
Average target price 32,67 $
Spread / Average Target 45,6%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer